Page 54 - Recognizing axial spondyloarthritis - Janneke de Winter

CHAPTER THREE
phenotype? Arthritis Rheum
2013;65:12–20.
13. Rudwaleit M, Khan MA, Sieper J.
Commentary: The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum 2005;52:1000–1008.
14. Poddubnyy D, Haibel H. Clinical course over two years in patients with early non-radiographic axial spondyloarthritis and ankylosing spondylitis without anti-tumour necrosis factor α treatment: results from the GErman SPondyloarthritis Inception Cohort. Arthritis Rheumatol 2015;67:2369–75.
15. Sieper J, Heijde D van der, Dougados M, Mease PJ, Maksymowych WP, Brown M a., et al. Efficacy and safety of adalimumab in patients with non- radiographic axial spondyloarthritis: results of a randomised placebo- controlled trial (ABILITY-1). Ann Rheum Dis 2012;72:815–822.
16. Song I-H, Weiß A, Hermann K-G a, Haibel H, Althoff CE, Poddubnyy D, et al. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial. Ann Rheum Dis 2013;72:823–5.
17. Callhoff J, Sieper J, Weiß A, Zink A, Listing J. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis 2015;74:1241–8.
18. McCormick D, McKnight J, Pendleton a. Anti-TNF response rates in radiographic and non-radiographic axial spondyloarthropathy. Ann
Rheum Dis 2014;74:e21–e21.
19. Berg R van den, Lenczner G, Feydy A, Heijde D Van Der, Reijnierse M, Saraux A, et al. Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs: Results from the DESIR cohort. Arthritis
Rheumatol 2014;66:2403–2411.
20. Tubergen a van, Heuft-Dorenbosch L, Schulpen G, Landewé R, Wijers R, Heijde D van der, et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann
Rheum Dis 2003;62:519–525.
21. Robinson PC, Wordsworth BP, Reveille JD, Brown M a. Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis. Ann Rheum
Dis 2013;72:162–4.
22. Haibel H, Rudwaleit M, Listing J,
Heldmann F, Wong RL, Kupper H, et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo- controlled trial followed by an open- label extension up to week fifty-two. Arthritis Rheum 2008;58:1981–1991.
23. Berg R van den, Hooge M de, Gaalen F van, Reijnierse M, Huizinga T, Heijde D van der. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 2013;52:1492–9.
24. Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink
52